Changes in the Hormonal and Inflammatory Profile of Young Sprint- and Endurance-trained Athletes. (CHIPYA)

November 29, 2023 updated by: Poznan University of Physical Education

Changes in the Hormonal and Inflammatory Profile of Young Sprint- and Endurance-trained Athletes Following a Sports Camp

One essential element of athlete training is conditioning camps, where athletes undergo a rigorous and targeted training schedule to prepare for upcoming sporting events. During sports camps, due to the accumulation of a large number of training units, including high-intensity exercises, athletes react with post-exercise overload, acute fatigue, and overreaching which can become a chronic overtraining syndrome. Overtraining syndrome is a very specific and severe condition where overtraining without adequate rest and recovery leads to performance decrements lasting more than 2-3 months, coupled with a mood disturbance. The exact etiology and pathogenesis are unknown and actively being investigated.

During training camps the balance between training volumes and recovery is often a delicate one and, the accumulation of exercise-induced stress may exceed the capacity of both neuroendocrine and immune adaptation leading to an alteration of physiological functions, decreasing adaptation to performance, impairment of psychological processing, immunological dysfunction, and biochemical abnormalities. Moreover, there is currently a lack of biomarkers accessible to assist in diagnosing and, what's even more important - help to prevent the overtraining syndrome, except for the continued presence of unexplained underperformance despite athletes' adequate rest and recovery.

Thus, this study aims to explain how long and intensive training for endurance affects the hormonal and immune systems of young athletes.

The main questions it aims to answer are:

  1. How does intense training influence hormonal and immune responses in young, trained athletes?
  2. Does training specialization affect the hormonal and immune response to intense training?

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Twenty-four young male and female athletes, specializing in athletics disciplines such as sprint (hurdles, 100m, 110m), and endurance: race walk, 5000m, and 10000m, volunteered to take part in this study. Investigation was held during 9 days of the training camp (preparatory period, general preparation sub-period), which was aimed at increasing the endurance and flexibility of athletes. During the training camp, all subjects occupied the same accommodations and followed the same training plan and diet schedules. The camp regime included 2 training sessions per day, lasting 4 hours per day, and a total of 21 hours per 9 days. Blood samples were taken always in the same conditions, from the antecubital veins. Participants were seated in a recumbent position for a minimum of 10 minutes before blood draws to stabilize the hydrostatic condition. Before collection of the first sample (rested baseline), participants were asked to avoid any intense exercise at least 24 hours before sampling. Next samples were taken after 4 days and after another 5 days of training camp (in total after 9 days). The concentration of catecholamines: epinephrine and norepinephrine in serum was measured as well and the responsiveness of the adrenal medulla to the sympathetic nervous activity was estimated by the ratio E/NE calculated. Also, concentrations of cortisol, hs-CRP, and myoglobin were measured and changes in blood morphology were estimated.

Study Type

Observational

Enrollment (Actual)

24

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Poznań, Poland, 61-871
        • Poznań University of Physical Education

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Twenty-four young male and female athletes, students at Sports Championship School, future representatives of the Polish National Team, specializing in athletics disciplines such as sprint (hurdles, 100m, 110m), and endurance: race walk, 5000m, and 10000m, volunteered to take part in this study.

Description

Inclusion Criteria:

  • age 15-17 years,
  • minimum of 3 years of training experience,
  • specialization in anaerobic and aerobic disciplines.

Exclusion Criteria:

  • presence of acute or chronic inflammation
  • fever, infections, injuries
  • se of any anti-inflammatory drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
sprint-trained
Sprint-trained athletes: 6 male and 6 female, aged average 15 y.,
Intense endurance training
endurance-trained
Endurance-trained athletes: 6 male and 6 female, aged average 15 y.,
Intense endurance training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in epinephrine serum level.
Time Frame: at rest baseline (before training), after 4 - and after another 5 days of training.
marker of HPA axis functioning, stress hormone.
at rest baseline (before training), after 4 - and after another 5 days of training.
Changes in norepinephrine serum level.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
marker of HPA axis functioning, stress hormone.
at rested baseline (before training), after 4 - and after another 5 days of training.
Changes in cortisol serum level.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
marker of HPA axis functioning, stress hormone
at rested baseline (before training), after 4 - and after another 5 days of training.
Changes in hs-CRP serum level.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
marker of inflammatory response.
at rested baseline (before training), after 4 - and after another 5 days of training.
Changes in Myoglobin serum level.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
marker of muscle damage
at rested baseline (before training), after 4 - and after another 5 days of training.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in blood morphology.
Time Frame: sat rested baseline (before training), after 4 - and after another 5 days of training.
Morphometric measurements of blood cell.
sat rested baseline (before training), after 4 - and after another 5 days of training.
Changes in epinephrine/norepinephrine ratio.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
marker of responsiveness of the adrenal medulla to sympathetic nervous activity.
at rested baseline (before training), after 4 - and after another 5 days of training.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joanna Ostapiuk-Karolczuk, Ph.D., Poznań University of Physical Education

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 16, 2018

Primary Completion (Actual)

February 24, 2018

Study Completion (Actual)

December 10, 2018

Study Registration Dates

First Submitted

November 13, 2023

First Submitted That Met QC Criteria

November 20, 2023

First Posted (Actual)

November 29, 2023

Study Record Updates

Last Update Posted (Estimated)

December 6, 2023

Last Update Submitted That Met QC Criteria

November 29, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 530/18

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overtraining Syndrome

Clinical Trials on Exercise training

Subscribe